Comparison of Delta-Shaped and Billroth II After TLDG (TLDG)
Primary Purpose
Gastric Cancer
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Delta-shaped anastomosis
Billroth II anastomosis
Sponsored by
About this trial
This is an interventional supportive care trial for Gastric Cancer focused on measuring Totally laparoscopic gastrectomy, laparoscopic distal gastrectomy, Intracorporeal anastomosis, Delta-Shaped Anastomosis, Billroth II Anastomosis, Gastric cancer
Eligibility Criteria
Inclusion Criteria:
- carcinoma located in the lower 1/3 of gastric body or antrum of stomach
- diagnosed by endoscopy ,endoscopic ultrasonography and abdominal CT scan
- diameter of the tumor <3cm
- no pyloric obstruction
Exclusion Criteria:
- diameter of the tumor ≥3cm
- associated with obstruction, bleeding, emergency surgery or surgical intervention
- tumor with extensive metastasis
- patient had previously undergone gastrostomy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Delta-shaped anastomosis group
Billroth II anastomosis group
Arm Description
The patients in DS group underwent Delta-shaped anastomosis after TLDG.
The patients in B-II group underwent Billroth-II anastomosis after TLDG.
Outcomes
Primary Outcome Measures
Stage distribution
Resected margin
Operative time
Anastomosis time
The number of stapler cartridges used
Median estimated blood loss
Red blood cell transfusion
Length of the incision
Secondary Outcome Measures
Postoperative complication
Major complications includes anastomosis leakage and intrabdominal bleeding . Minor complications includes bile regurgitation,anastomotic stenosis and delayed gastric emptying.
Full Information
NCT ID
NCT02372747
First Posted
January 22, 2015
Last Updated
February 21, 2015
Sponsor
The First Hospital of Jilin University
1. Study Identification
Unique Protocol Identification Number
NCT02372747
Brief Title
Comparison of Delta-Shaped and Billroth II After TLDG
Acronym
TLDG
Official Title
Comparison of Delta-Shaped and Billroth II for Intracorporeal Anastomosis After Totally Laparoscopic Distal Gastrectomy for Gastric Cancer
Study Type
Interventional
2. Study Status
Record Verification Date
February 2006
Overall Recruitment Status
Completed
Study Start Date
October 2012 (undefined)
Primary Completion Date
November 2013 (Actual)
Study Completion Date
December 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The First Hospital of Jilin University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To compare the safety and feasibility of Delta-shaped anastomosis and Billroth II anastomosis after totally laparoscopic distal gastrectomy for gastric cancer(TLDG).
Detailed Description
Methods: 78 consecutive patients who underwent TLDG in First Hospital of Jilin University between October 2012 and December 2014 were enrolled in this study . All patients were divided randomly into two groups:Delta-shaped anastomosis group (DS group) and Billroth II anastomosis group (B-II group), and the patients in DS group underwent Delta-shaped anastomosis after TLDG, and the patients in B-II group underwent Billroth-II anastomosis after TLDG.Outcome measures,resected margin,operative time,anastomosis time,number of stapler cartridges used,length of the incision,the time of first flatus and liquid diet,hospital stay and postoperative morbidity are compared between the two groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastric Cancer
Keywords
Totally laparoscopic gastrectomy, laparoscopic distal gastrectomy, Intracorporeal anastomosis, Delta-Shaped Anastomosis, Billroth II Anastomosis, Gastric cancer
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
78 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Delta-shaped anastomosis group
Arm Type
Experimental
Arm Description
The patients in DS group underwent Delta-shaped anastomosis after TLDG.
Arm Title
Billroth II anastomosis group
Arm Type
Experimental
Arm Description
The patients in B-II group underwent Billroth-II anastomosis after TLDG.
Intervention Type
Procedure
Intervention Name(s)
Delta-shaped anastomosis
Intervention Description
The patients in DS group underwent Delta-shaped anastomosis after TLDG.
Intervention Type
Procedure
Intervention Name(s)
Billroth II anastomosis
Intervention Description
The patients in B-II group underwent Billroth-II anastomosis after TLDG.
Primary Outcome Measure Information:
Title
Stage distribution
Time Frame
up to 7 days after the operation
Title
Resected margin
Time Frame
up to 7 days after the operation
Title
Operative time
Time Frame
up to 7 days after the operation
Title
Anastomosis time
Time Frame
up to 7 days after the operation
Title
The number of stapler cartridges used
Time Frame
up to 7 days after the operation
Title
Median estimated blood loss
Time Frame
up to 7 days after the operation
Title
Red blood cell transfusion
Time Frame
up to 7 days after the operation
Title
Length of the incision
Time Frame
up to 7 days after the operation
Secondary Outcome Measure Information:
Title
Postoperative complication
Description
Major complications includes anastomosis leakage and intrabdominal bleeding . Minor complications includes bile regurgitation,anastomotic stenosis and delayed gastric emptying.
Time Frame
up to 30 days after the operation
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
carcinoma located in the lower 1/3 of gastric body or antrum of stomach
diagnosed by endoscopy ,endoscopic ultrasonography and abdominal CT scan
diameter of the tumor <3cm
no pyloric obstruction
Exclusion Criteria:
diameter of the tumor ≥3cm
associated with obstruction, bleeding, emergency surgery or surgical intervention
tumor with extensive metastasis
patient had previously undergone gastrostomy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Quan Wang, Doctor
Organizational Affiliation
The First Hospital of Jilin University
Official's Role
Study Director
12. IPD Sharing Statement
Learn more about this trial
Comparison of Delta-Shaped and Billroth II After TLDG
We'll reach out to this number within 24 hrs